Regeneron Pharmaceuticals, Inc. Common Stock (REGN) - Nasdaq
Discover real-time Regeneron Pharmaceuticals, Inc. Common Stock (REGN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay …
Regeneron Pharmaceuticals, Inc. Common Stock (REGN) Real-Time …
Get real-time updates on Regeneron Pharmaceuticals, Inc. Common Stock (REGN) stock quotes, trades, and more. Make informed investments with Nasdaq.
Regeneron Pharmaceuticals to Report Fourth Quarter and Full
Jan 7, 2025 · Regeneron Pharmaceuticals will share its fourth quarter and full year 2024 financial results, indicating transparency and commitment to informing stakeholders about its performance.
Leerink Partners Upgrades Regeneron Pharmaceuticals (REGN
Jan 28, 2025 · Fintel reports that on February 5, 2025, Leerink Partners upgraded their outlook for Regeneron Pharmaceuticals (NasdaqGS:REGN) from Market Perform to Outperform.
Regeneron Reports Positive Three-Year Results for EYLEA HD
3 days ago · TARRYTOWN, N.Y., Feb. 08, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive three-year (156-week) …
Regeneron to Highlight Pioneering Pipeline Progress Across
Nov 13, 2024 · --Regeneron Pharmaceuticals, Inc. today announced new and updated data from its hematology pipeline will be shared across 23 abstracts at the American Society of …
America's Top 40 High School Scientists to Compete for $1.8
Jan 23, 2025 · Regeneron Science Talent Search alumni have gone on to win 13 Nobel Prizes, 23 MacArthur Fellowships, and have founded numerous world-changing companies, including …
Regeneron Beats on Q4 Earnings, Initiates Quarterly Dividend
Feb 4, 2025 · Regeneron Pharmaceuticals, Inc. REGN reported fourth-quarter 2024 earnings per share (EPS) of $12.07, which beat the Zacks Consensus Estimate of $11.62. The company …
Regeneron and Truveta Announce Strategic Collaboration for the …
Jan 13, 2025 · Regeneron collaborates with Truveta to expand a genomic database, investing $119.5 million to enhance genetics-based healthcare research.
REGENERON PHARMACEUTICALS Earnings Results: $REGN …
Feb 4, 2025 · REGENERON PHARMACEUTICALS ($REGN) posted quarterly earnings results on Tuesday, February 4th. The company reported earnings of $12.07 per share, beating …